Aarti Drugs Ltd vs Albert David Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 12, 2026

Key Highlights

The Latest Trading Price of Aarti Drugs Ltd is ₹ 371.85 as of 12 Jun 09:45 . The P/E Ratio of Aarti Drugs Ltd changed from 23.1 on March 2021 to 18.5 on March 2025 . This represents a CAGR of -4.34% over 5 yearsThe P/E Ratio of Albert David Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Aarti Drugs Ltd changed from ₹ 6475 crore on March 2021 to ₹ 3123 crore on March 2025 . This represents a CAGR of -13.57% over 5 yearsThe Market Cap of Albert David Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Aarti Drugs Ltd for the Mar '26 is ₹ 721.06 crore as compare to the Dec '25 revenue of ₹ 602.94 crore. This represent the growth of 19.59% The revenue of Albert David Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Aarti Drugs Ltd for the Mar '26 is ₹ 96.56 crore as compare to the Dec '25 ebitda of ₹ 56.26 crore. This represent the growth of 71.63% The ebitda of Albert David Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Aarti Drugs Ltd changed from ₹ 33.27 crore to ₹ 55.26 crore over 8 quarters. This represents a CAGR of 28.88% The net profit of Albert David Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The Dividend Payout of Aarti Drugs Ltd changed from 9.04 % on March 2021 to 5.8 % on March 2025 . This represents a CAGR of -8.49% over 5 yearsThe Dividend Payout of Albert David Ltd changed from 15.47 % on March 2021 to 16.6 % on March 2025 . This represents a CAGR of 1.42% over 5 years .

About Aarti Drugs Ltd

Aarti Drugs Limited (ADL), incorporated in September, 1984 is a prominent manufacturer of APIs, Pharma Intermediates, and Specialty Chemicals.
The Company operates as part of the Aarti Group, a conglomerate with a net worth of USD 900 million.
With over 50 compounds for Antibiotics, Anti Protozoal, Anti-Inflammatory, Anti-diabetic, Anti Fungal and Cardioprotectant therapeutic segments, the Company has emerged as market leader in APIs.
Company also operates Pinnacle Life Science Private Limited, its wholly owned subsidiary focused on formulation development. The Company has two R&D divisions, one in Tarapur and the other in Turbhe, Maharashtra.
It has 3 subsidiaries, namely, Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited and Pinnacle Chile SpA (foreign subsidiary).

About Albert David Ltd

Albert David Limited (ADL), a Unit of Kothari Group, was incorporated in 1938 at Calcutta.
The Company belongs to a renowned industrial house of Kolkata, the 'Kothari Group'.
The Company's principal business is manufacturing and trading of Pharmaceutical Formulations, Infusion Solutions, Herbal Dosage Forms and Bulk Drugs by way of domestic sale or export.
Apart from these, it manufactures disposable syringes and needles and a wide range of bulk drugs.
It is recognised as a large IV fluid manufacturer, both in glass and polyethylene containers. ADL has entered into a technical collaboration with Morishita Pharmaceuticals, Japan, a subsidiary of Ajinomoto -- the world leader in amino acids -- to manufacture amino acid infusions, for which it came out with a rights issue in Aug.'87.

FAQs for the comparison of Aarti Drugs Ltd and Albert David Ltd

Which company has a larger market capitalization, Aarti Drugs Ltd or Albert David Ltd?

Market cap of Aarti Drugs Ltd is 3,358 Cr while Market cap of Albert David Ltd is 397 Cr

What are the key factors driving the stock performance of Aarti Drugs Ltd and Albert David Ltd?

The stock performance of Aarti Drugs Ltd and Albert David Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aarti Drugs Ltd and Albert David Ltd?

As of June 12, 2026, the Aarti Drugs Ltd stock price is INR ₹368.0. On the other hand, Albert David Ltd stock price is INR ₹696.75.

How do dividend payouts of Aarti Drugs Ltd and Albert David Ltd compare?

To compare the dividend payouts of Aarti Drugs Ltd and Albert David Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.